These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 22533275)

  • 1. What's the agenda?
    Carlson J
    Mod Healthc; 2011 Jul; 41(30):28-9. PubMed ID: 22533275
    [No Abstract]   [Full Text] [Related]  

  • 2. Medicine and the pharmaceutical industry: what's right, what's wrong, and what's to come.
    Tan SY
    Singapore Med J; 1998 Mar; 39(3):91-5. PubMed ID: 9632964
    [No Abstract]   [Full Text] [Related]  

  • 3. What's brewing in genetic testing.
    Nat Genet; 2002 Dec; 32(4):553-4. PubMed ID: 12457183
    [No Abstract]   [Full Text] [Related]  

  • 4. Gifts. What's all the fuss about?
    Murray D
    Med Econ; 2002 Oct; 79(19):119-20. PubMed ID: 12407814
    [No Abstract]   [Full Text] [Related]  

  • 5. US advisory panellists on drug's safety had ties to manufacturers.
    Lenzer J; Epstein K
    BMJ; 2012 Jan; 344():e244. PubMed ID: 22234908
    [No Abstract]   [Full Text] [Related]  

  • 6. Designer drugs. What's best for patients isn't always what's best for profits.
    Sherrid P
    US News World Rep; 2001 Aug; 131(6):30-2. PubMed ID: 11508075
    [No Abstract]   [Full Text] [Related]  

  • 7. One year after launch, drug safety board is dubbed a failure.
    Wadman M
    Nat Med; 2006 Mar; 12(3):258. PubMed ID: 16520751
    [No Abstract]   [Full Text] [Related]  

  • 8. American council on science and health.
    Moynihan R
    BMJ; 2010 Apr; 340():c1819. PubMed ID: 20375090
    [No Abstract]   [Full Text] [Related]  

  • 9. US proposes more stringent conflict-of-interest rules.
    Kondro W
    CMAJ; 2007 May; 176(11):1571-2. PubMed ID: 17515579
    [No Abstract]   [Full Text] [Related]  

  • 10. Process analytical technology and ASTM Committee E55.
    Watts DC; Afnan AM; Hussain AS
    Stand News; 2004 May; 32(5):25-7. PubMed ID: 15146856
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic testing: what's here, what's ahead.
    Lippman H
    MLO Med Lab Obs; 2000 Aug; 32(8):10, 12. PubMed ID: 11183640
    [No Abstract]   [Full Text] [Related]  

  • 12. Guidance for guidelines.
    Steinbrook R
    N Engl J Med; 2007 Jan; 356(4):331-3. PubMed ID: 17251529
    [No Abstract]   [Full Text] [Related]  

  • 13. Serving on the practicing physicians advisory council.
    Rothhammer A
    Bull Am Coll Surg; 2002 Mar; 87(3):26-8. PubMed ID: 17387862
    [No Abstract]   [Full Text] [Related]  

  • 14. Committee E55 on process analytical technology: a supplier's perspective.
    Clegg I
    Stand News; 2004 May; 32(5):28-31. PubMed ID: 15146857
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trials and public trust.
    Kennedy D
    Science; 2004 Dec; 306(5702):1649. PubMed ID: 15576574
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA revamps committee conflict-of-interest rules.
    Finkelstein JB
    J Natl Cancer Inst; 2006 Oct; 98(19):1354-5. PubMed ID: 17018777
    [No Abstract]   [Full Text] [Related]  

  • 17. President's message. What's happening to our drugs?
    Stricker EA
    Mo Med; 1973 Nov; 70(11):779. PubMed ID: 4753032
    [No Abstract]   [Full Text] [Related]  

  • 18. Advisors may urge NIH to seek out industry support for clinical trials.
    Appel A
    Nature; 1995 Nov; 378(6553):116. PubMed ID: 7477301
    [No Abstract]   [Full Text] [Related]  

  • 19. Clarifying the dispute over academic-industry relationships.
    Huddle TS
    Am J Bioeth; 2011 Jan; 11(1):47-9. PubMed ID: 21240812
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of a professional organization on physician behavior.
    Orentlicher D
    Albany Law Rev; 1994; 57(3):583-605. PubMed ID: 11652855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.